MEDIROM Healthcare Technologies (MRM) Research Hub

MEDIROM Healthcare Technologies (MRM) trades on NASDAQ, JP in the Consumer Cyclical (Personal Products & Services) sector. As of 2026-09-11, shares last closed at 0.83 USD (-8.80%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.14, market cap 0.00B. This hub links to the full technical, earnings and options research available for MRM.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorConsumer Cyclical (Personal Products & Services)
ExchangeNASDAQ, JP
Last close0.83 USD (-8.80%)
52-week range0.7902 USD – 1.19 USD
Trend regimeRange
14-day RSI35.6 (Bearish)
Trailing P/E-2.14
Market cap0.00B
Dividend yield0.00%

Available research for MRM

Earnings

MRM earnings: real EPS beat/miss history, analyst consensus Buy, P/E -2.14. Updated 2026-07-23.

Options: Covered Call

Covered Call on MRM: how it works, illustrative setup around the real 0.83 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on MRM: how it works, illustrative setup around the real 0.83 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on MRM: how it works, illustrative setup around the real 0.83 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

MRM technical analysis: range, last 0.83 USD, RSI 35.6, 52w range 0.7902 USD–1.19 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is MRM in?

MEDIROM Healthcare Technologies (MRM) is classified under Consumer Cyclical (Personal Products & Services), listed on NASDAQ, JP.

Is MRM in an uptrend or downtrend?

As of 2026-09-11, MRM is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is MRM's trailing P/E ratio?

MRM's trailing P/E is -2.14, with a market cap of 0.00B. See the earnings research page for full valuation detail.